. 2019 Jun 30;28(2):103–109. doi: 10.5978/islsm.19-OR-06

Table 2: VHI Score and VVA Symptoms.

	Baseline	12MFU^b	15MFU^c	18MFU
VHIS	12.4 ± 4.0^*	16.3 ± 4.5^*	16.9 ± 4.6^*	17.1 ± 4.6^*
Vaginal itching^a	1.2 ± 2.0^*	0.8 ± 1.2^*	0.6 ± 1.1^*	0.4 ± 0.6^*
Vaginal burning^a	1.8 ± 2.6^*	0.6 ± 0.9^*	0.6 ± 0.9^*	0.4 ± 0.7^*
Vaginal dryness^a	4.7 ± 3.1^*	2.3 ± 2.2^*	2.0 ± 2.0^*	1.5 ± 1.6^*
Dyspareunia (Pain during intercourse)^a	5.8 ± 3.4^*	2.9 ± 2.8^*	3.0 ± 2.6^*	2.0 ± 2.4^*
Dysuria (Pain/stinging during urination)^a	1.3 ± 2.4^*	0.6 ± 1.2^*	0.5 ± 0.8^*	0.2 ± 0.4^*

Data is presented as mean ± standard deviation.

Data is measured on a VAS scale (range 0–10).

2 subjects were treated at the 12MFU visit;

13 subjects were treated at the 15MFU visit;

Significant change from baseline (p < 0.05) according to SAS Mixed model

MFU: months of follow-up after the third laser treatment.